311 related articles for article (PubMed ID: 14638551)
1. Adenovirus-mediated gene transfer of transforming growth factor-beta3, but not transforming growth factor-beta1, inhibits constrictive remodeling and reduces luminal loss after coronary angioplasty.
Kingston PA; Sinha S; Appleby CE; David A; Verakis T; Castro MG; Lowenstein PR; Heagerty AM
Circulation; 2003 Dec; 108(22):2819-25. PubMed ID: 14638551
[TBL] [Abstract][Full Text] [Related]
2. Adenovirus-mediated gene transfer of a secreted transforming growth factor-beta type II receptor inhibits luminal loss and constrictive remodeling after coronary angioplasty and enhances adventitial collagen deposition.
Kingston PA; Sinha S; David A; Castro MG; Lowenstein PR; Heagerty AM
Circulation; 2001 Nov; 104(21):2595-601. PubMed ID: 11714656
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of late lumen loss after antiproliferative percutaneous coronary intervention using beta-irradiation in a porcine model of restenosis.
Deiner C; Loddenkemper C; Rauch U; Rosenthal P; Pauschinger M; Schwimmbeck PL; Schultheiss HP; Pels K
Cardiovasc Revasc Med; 2007; 8(2):94-8. PubMed ID: 17574167
[TBL] [Abstract][Full Text] [Related]
4. Periluminal expression of a secreted transforming growth factor-β type II receptor inhibits in-stent neointima formation following adenovirus-mediated stent-based intracoronary gene transfer.
Appleby CE; Ranjzad P; Williams PD; Kakar SJ; Driessen A; Tijsma E; Fernandes B; Heagerty AM; Kingston PA
Hum Gene Ther; 2014 May; 25(5):443-51. PubMed ID: 24483849
[TBL] [Abstract][Full Text] [Related]
5. Adenoviral delivery of an antisense RNA complementary to the 3' coding sequence of transforming growth factor-beta1 inhibits fibrogenic activities of hepatic stellate cells.
Arias M; Lahme B; Van de Leur E; Gressner AM; Weiskirchen R
Cell Growth Differ; 2002 Jun; 13(6):265-73. PubMed ID: 12114216
[TBL] [Abstract][Full Text] [Related]
6. Changes in extracellular matrix and in transforming growth factor beta isoforms after coronary artery ligation in rats.
Deten A; Hölzl A; Leicht M; Barth W; Zimmer HG
J Mol Cell Cardiol; 2001 Jun; 33(6):1191-207. PubMed ID: 11444923
[TBL] [Abstract][Full Text] [Related]
7. [Influence of recombinant transforming growth factor-beta3 on collagen synthesis and deposition: experiment with rat cell model of liver fibrosis].
Li Q; Zhou X; Yu J; Qian W; Xu KS
Zhonghua Yi Xue Za Zhi; 2008 May; 88(18):1273-8. PubMed ID: 18844103
[TBL] [Abstract][Full Text] [Related]
8. Understanding the role of transforming growth factor-beta1 in intimal thickening after vascular injury.
Khan R; Agrotis A; Bobik A
Cardiovasc Res; 2007 May; 74(2):223-34. PubMed ID: 17349984
[TBL] [Abstract][Full Text] [Related]
9. Growth factor effects on passaged TMJ disk cells in monolayer and pellet cultures.
Allen KD; Athanasiou KA
Orthod Craniofac Res; 2006 Aug; 9(3):143-52. PubMed ID: 16918679
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta isoforms differently stimulate proalpha2 (I) collagen gene expression during wound healing process in transgenic mice.
Kinbara T; Shirasaki F; Kawara S; Inagaki Y; de Crombrugghe B; Takehara K
J Cell Physiol; 2002 Mar; 190(3):375-81. PubMed ID: 11857453
[TBL] [Abstract][Full Text] [Related]
11. Smad7 gene transfer attenuates adventitial cell migration and vascular remodeling after balloon injury.
Mallawaarachchi CM; Weissberg PL; Siow RC
Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1383-7. PubMed ID: 15860740
[TBL] [Abstract][Full Text] [Related]
12. The bioactivity of transforming growth factor-beta1 can be regulated via binding to dermal collagens in mink lung epithelial cells.
Shibuya H; Okamoto O; Fujiwara S
J Dermatol Sci; 2006 Mar; 41(3):187-95. PubMed ID: 16337361
[TBL] [Abstract][Full Text] [Related]
13. Catheter-based adenovirus-mediated local intravascular gene delivery of a soluble TGF-beta type II receptor using an infiltrator in porcine coronary arteries: efficacy and complications.
Chung IM; Ueno H; Pak YK; Kim JW; Choi DH; Shin GJ; Yang WI; Jang Ys
Exp Mol Med; 2002 Sep; 34(4):299-307. PubMed ID: 12515396
[TBL] [Abstract][Full Text] [Related]
14. Intimal hyperplasia and expression of transforming growth factor-beta1 in saphenous veins and internal mammary arteries before coronary artery surgery.
Friedl R; Li J; Schumacher B; Hanke H; Waltenberger J; Hannekum A; Stracke S
Ann Thorac Surg; 2004 Oct; 78(4):1312-8. PubMed ID: 15464491
[TBL] [Abstract][Full Text] [Related]
15. Troglitazone inhibits synthesis of transforming growth factor-beta1 and reduces matrix production in human peritoneal mesothelial cells.
Peng Y; Liu H; Liu F; Liu Y; Li J; Chen X
Nephrology (Carlton); 2006 Dec; 11(6):516-23. PubMed ID: 17199790
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta1 antisense treatment of rat vein grafts reduces the accumulation of collagen and increases the accumulation of h-caldesmon.
Wolff RA; Malinowski RL; Heaton NS; Hullett DA; Hoch JR
J Vasc Surg; 2006 May; 43(5):1028-36. PubMed ID: 16678700
[TBL] [Abstract][Full Text] [Related]
17. VEGF regulates FGF-2 and TGF-beta1 expression in injury endothelial cells and mediates smooth muscle cells proliferation and migration.
Li D; Zhang C; Song F; Lubenec I; Tian Y; Song QH
Microvasc Res; 2009 Mar; 77(2):134-42. PubMed ID: 18948122
[TBL] [Abstract][Full Text] [Related]
18. Antisense to transforming growth factor-beta1 messenger RNA reduces vein graft intimal hyperplasia and monocyte chemotactic protein 1.
Wolff RA; Ryomoto M; Stark VE; Malinowski R; Tomas JJ; Stinauer MA; Hullett DA; Hoch JR
J Vasc Surg; 2005 Mar; 41(3):498-508. PubMed ID: 15838486
[TBL] [Abstract][Full Text] [Related]
19. Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung.
Sime PJ; Xing Z; Graham FL; Csaky KG; Gauldie J
J Clin Invest; 1997 Aug; 100(4):768-76. PubMed ID: 9259574
[TBL] [Abstract][Full Text] [Related]
20. Differential cataractogenic potency of TGF-beta1, -beta2, and -beta3 and their expression in the postnatal rat eye.
Gordon-Thomson C; de Iongh RU; Hales AM; Chamberlain CG; McAvoy JW
Invest Ophthalmol Vis Sci; 1998 Jul; 39(8):1399-409. PubMed ID: 9660488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
